ROLE OF LUTETIUM-177 RADIOLABELED SMALL MOLECULE TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AN EARLY TREATMENT OPTION IN PROSTATE CANCER

| Funding period: 2020 - 2021

Active

Researchers